Literature DB >> 18285457

Spatial interplay between PIASy and FIP200 in the regulation of signal transduction and transcriptional activity.

Nadine Martin1, Klaus Schwamborn, Henning Urlaub, Boyi Gan, Jun-Lin Guan, Anne Dejean.   

Abstract

The members of the protein inhibitor of activated STAT (PIAS) family of proteins are implicated in fundamental cellular processes, including transcriptional regulation, either through action as E3 SUMO ligases or through SUMO-independent effects. We report here the identification of FIP200 (focal adhesion kinase family-interacting protein of 200 kDa) as a new PIASy-interacting protein. We show that the interaction depends on the integrity of the RING finger of PIASy and the carboxy terminus of FIP200. Both in vitro and in vivo sumoylation assays failed to reveal any sumoylation of FIP200, suggesting that FIP200 is not a bona fide SUMO substrate. Immunofluorescence microscopy and subcellular fractionation, either upon forced PIASy expression or in the absence of PIASy, revealed that interaction with PIASy redistributes FIP200 from the cytoplasm to the nucleus, correlating with abrogation of FIP200 regulation of TSC/S6K signaling. Conversely, FIP200 enhances the transcriptional activation of the p21 promoter by PIASy whereas PIASy transcription activity is severely reduced upon FIP200 depletion by RNA interference. Chromatin immunoprecipitation analysis demonstrates that endogenous PIASy and FIP200 are corecruited to the p21 promoter. Altogether, these results provide the first evidence for the existence of a close-spatially controlled-mode of regulation of FIP200 and PIASy nucleocytoplasmic functions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18285457      PMCID: PMC2293096          DOI: 10.1128/MCB.01210-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

Review 1.  SUMO: a history of modification.

Authors:  Ronald T Hay
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

2.  SUMO-1 modification of PIASy, an E3 ligase, is necessary for PIASy-dependent activation of Tcf-4.

Authors:  Motomasa Ihara; Hideki Yamamoto; Akira Kikuchi
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

Review 3.  Regulation of gene-activation pathways by PIAS proteins in the immune system.

Authors:  Ke Shuai; Bin Liu
Journal:  Nat Rev Immunol       Date:  2005-08       Impact factor: 53.106

Review 4.  Something about SUMO inhibits transcription.

Authors:  Grace Gill
Journal:  Curr Opin Genet Dev       Date:  2005-10       Impact factor: 5.578

5.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels.

Authors:  A Shevchenko; M Wilm; O Vorm; M Mann
Journal:  Anal Chem       Date:  1996-03-01       Impact factor: 6.986

6.  Disruption of the murine PIASx gene results in reduced testis weight.

Authors:  H Santti; L Mikkonen; A Anand; S Hirvonen-Santti; J Toppari; M Panhuysen; F Vauti; M Perera; G Corte; W Wurst; O A Jänne; J J Palvimo
Journal:  J Mol Endocrinol       Date:  2005-06       Impact factor: 5.098

7.  Specific inhibition of Stat3 signal transduction by PIAS3.

Authors:  C D Chung; J Liao; B Liu; X Rao; P Jay; P Berta; K Shuai
Journal:  Science       Date:  1997-12-05       Impact factor: 47.728

8.  Mechanism of cell cycle regulation by FIP200 in human breast cancer cells.

Authors:  Zara K Melkoumian; Xu Peng; Boyi Gan; Xiaoyang Wu; Jun-Lin Guan
Journal:  Cancer Res       Date:  2005-08-01       Impact factor: 12.701

9.  Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor.

Authors:  Anna Saramäki; Claire M Banwell; Moray J Campbell; Carsten Carlberg
Journal:  Nucleic Acids Res       Date:  2006-01-24       Impact factor: 16.971

10.  Identification of FIP200 interaction with the TSC1-TSC2 complex and its role in regulation of cell size control.

Authors:  Boyi Gan; Zara K Melkoumian; Xiaoyang Wu; Kun-Liang Guan; Jun-Lin Guan
Journal:  J Cell Biol       Date:  2005-07-25       Impact factor: 10.539

View more
  13 in total

Review 1.  PIAS proteins: pleiotropic interactors associated with SUMO.

Authors:  Miia M Rytinki; Sanna Kaikkonen; Petri Pehkonen; Tiina Jääskeläinen; Jorma J Palvimo
Journal:  Cell Mol Life Sci       Date:  2009-06-13       Impact factor: 9.261

2.  PARP-1 transcriptional activity is regulated by sumoylation upon heat shock.

Authors:  Nadine Martin; Klaus Schwamborn; Valérie Schreiber; Andreas Werner; Christelle Guillier; Xiang-Dong Zhang; Oliver Bischof; Jacob-S Seeler; Anne Dejean
Journal:  EMBO J       Date:  2009-09-24       Impact factor: 11.598

3.  Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis.

Authors:  Huijun Wei; Shuang Wei; Boyi Gan; Xu Peng; Weiping Zou; Jun-Lin Guan
Journal:  Genes Dev       Date:  2011-07-15       Impact factor: 11.361

4.  Caveolin-3 undergoes SUMOylation by the SUMO E3 ligase PIASy: sumoylation affects G-protein-coupled receptor desensitization.

Authors:  Stephen R Fuhs; Paul A Insel
Journal:  J Biol Chem       Date:  2011-03-01       Impact factor: 5.157

5.  RB1CC1 protein suppresses type II collagen synthesis in chondrocytes and causes dwarfism.

Authors:  Ichiro Nishimura; Tokuhiro Chano; Hiroko Kita; Yoshitaka Matsusue; Hidetoshi Okabe
Journal:  J Biol Chem       Date:  2011-11-02       Impact factor: 5.157

6.  Screening for microsatellite instability identifies frequent 3'-untranslated region mutation of the RB1-inducible coiled-coil 1 gene in colon tumors.

Authors:  Bogdan C Paun; Yulan Cheng; Barbara A Leggett; Joanne Young; Stephen J Meltzer; Yuriko Mori
Journal:  PLoS One       Date:  2009-11-02       Impact factor: 3.240

7.  RB1CC1 activates RB1 pathway and inhibits proliferation and cologenic survival in human cancer.

Authors:  Tokuhiro Chano; Kaichiro Ikebuchi; Yasuko Ochi; Hitosuke Tameno; Yasuhiko Tomita; Yufen Jin; Hideo Inaji; Makoto Ishitobi; Koji Teramoto; Ichiro Nishimura; Kahori Minami; Hirokazu Inoue; Takahiro Isono; Masao Saitoh; Taketoshi Shimada; Yasuo Hisa; Hidetoshi Okabe
Journal:  PLoS One       Date:  2010-06-30       Impact factor: 3.240

8.  Inactivation of FIP200 leads to inflammatory skin disorder, but not tumorigenesis, in conditional knock-out mouse models.

Authors:  Huijun Wei; Boyi Gan; Xiaoyang Wu; Jun-Lin Guan
Journal:  J Biol Chem       Date:  2008-12-23       Impact factor: 5.157

9.  RB1CC1 together with RB1 and p53 predicts long-term survival in Japanese breast cancer patients.

Authors:  Tokuhiro Chano; Kaichiro Ikebuchi; Yasuhiko Tomita; Yufen Jin; Hideo Inaji; Makoto Ishitobi; Koji Teramoto; Yasuko Ochi; Hitosuke Tameno; Ichiro Nishimura; Kahori Minami; Hirokazu Inoue; Takahiro Isono; Masao Saitoh; Taketoshi Shimada; Yasuo Hisa; Hidetoshi Okabe
Journal:  PLoS One       Date:  2010-12-22       Impact factor: 3.240

10.  Preparation of mouse monoclonal antibody for RB1CC1 and its clinical application.

Authors:  Yusuke Hama; Tokuhiro Chano; Takuma Inui; Kyoichi Matsumoto; Hidetoshi Okabe
Journal:  PLoS One       Date:  2012-03-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.